• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Rosecliff Acquisition Corp I

    2/14/22 4:11:43 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care
    Get the next $RCLF alert in real time by email
    SC 13G 1 ea155635-13gsponsor_rose1.htm SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    (Amendment No. )*

     

    Under the Securities Exchange Act of 1934

     

                      Rosecliff Acquisition Corp I                

    (Name of Issuer)

     

                       Class A Common Stock, par value $0.0001 per share                

    (Titles of Class of Securities)

     

                                  77732R103                             

    (CUSIP Number)

     

                               December 31, 2021                            

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out of a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    1

    NAME OF REPORTING PERSON

     

    Rosecliff Acquisition Sponsor I LLC

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY

     

    4 CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5 SOLE VOTING POWER

    0
    6 SHARED VOTING POWER

    6,195,000 (1)
    7

    SOLE DISPOSITIVE POWER

     

    0

     

    8 SHARED DISPOSITIVE POWER

    6,195,000 (1)

    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    6,195,000 (1)
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    19.7% (2)
    12

    TYPE OF REPORTING PERSON

     

    OO

     

    (1)Reflects 6,325,000 shares of Rosecliff Acquisition Corp I (the “Company”) Class A common stock, par value $0.0001 per share (“Class A Common Stock”), issuable upon conversion of 6,195,000 shares of the Company’s Class B common stock, par value $0.0001 per share (“Class B Common Stock”), held directly by Rosecliff Acquisition Sponsor I LLC (the “Sponsor”). The Class B Common Stock will automatically convert into Class A Common Stock at the time of the Company’s initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment.

     

    (2)The calculation assumes that there is a total of 31,495,000 shares of Class A Common Stock outstanding, which is the sum of (i) the 25,300,000 shares of Class A Common Stock outstanding as of November 22, 2021, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 (the “Report”), and (ii) the 6,195,000 shares of Class A Common Stock issuable upon conversion of the Class B Common Stock held by the Sponsor.

     

    2

     

     

    1

    NAME OF REPORTING PERSON

     

    Michael Murphy

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY

     

    4 CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5 SOLE VOTING POWER

    0
    6 SHARED VOTING POWER

    6,195,000 (1)
    7

    SOLE DISPOSITIVE POWER

     

    0

     

    8 SHARED DISPOSITIVE POWER

    6,195,000 (1)

    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    6,195,000 (1)
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    19.7% (2)
    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Reflects 6,195,000 shares of Class A Common Stock issuable upon conversion of 6,195,000 shares of Class B Common Stock held by the Sponsor. The Class B Common Stock will automatically convert into Class A Common Stock at the time of the Company’s initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. Rosecliff Credit Opportunity Fund I, L.P (“RSO”) is the managing member of the Sponsor. Rosecliff Credit Opportunity Fund I GP, LLC (“Fund”) is the general partner of RSO. Michael Murphy is the managing member of Fund. As a result of the foregoing, Mr. Murphy may be deemed to beneficially own shares held by the Sponsor.

     

    (2)The calculation assumes that there is a total of 31,495,000 shares of Class A Common Stock outstanding, which is the sum of (i) the 25,300,000 shares of Class A Common Stock outstanding as of November 22, 2021, as reported in the Company’s Quarterly Report on Form 10-Q for the Report, and (ii) the 6,195,000 shares of Class A Common Stock issuable upon conversion of the Class B Common Stock held by the Sponsor.

     

    3

     

     

    Item 1(a).Name of Issuer:

     

    Rosecliff Acquisition Corp I

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

    767 5th Avenue, 34th Floor, New York, NY 10153

     

    Item 2(a).Name of Person Filing:

     

    This statement is being filed jointly pursuant to §240.13d-1(k)(1) on behalf of each of the following persons (collectively, the “Reporting Persons”):

     

    1. Rosecliff Acquisition Sponsor I LLC

    2. Michael Murphy

     

    Item 2(b).Address of Principal Business Office or, if none, Residence:

     

    The principal business address of each of the Reporting Persons is as follows:

     

    767 5th Avenue, 34th Floor, New York, NY 10153

     

    Item 2(c).Citizenship:

     

    See responses to Item 4 on each cover page.

     

    Item 2(d).Titles of Classes of Securities:

     

    Class A Common Stock, par value $0.0001 per share

     

    Item 2(e).CUSIP Number:

     

    77732R103

     

    Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

     

      (a) ☐ Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o).
           
      (b) ☐ Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
           
      (c) ☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
           
      (d) ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) ☐ Investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
           
      (f) ☐ Employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
           
      (g) ☐ Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

     

    4

     

     

      (h) ☐ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
           
      (i) ☐ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
           
      (j) ☐ Non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).
           
      (k) ☐ Group in accordance with §240.13d-1(b)(1)(ii)(K).
           
      If filing as a non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J), please specify the type of institution: ______________ .

     

    Item 4.Ownership  

     

    (a)Amount beneficially owned:

     

    See response to Item 9 on each cover page.

     

    (b)Percent of class:

     

    See response to Item 11 on each cover page.

     

    (c)Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote:

     

    See response to Item 5 on each cover page.

     

    (ii) Shared power to vote or to direct the vote:

     

    See response to Item 6 on each cover page.

     

    (iii) Sole power to dispose or to direct the disposition of:

     

    See response to Item 7 on each cover page.

     

    (iv) Shared power to dispose or to direct the disposition of:

     

    See response to Item 8 on each cover page.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.  

     

    Not Applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not Applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10.Certification.  

     

    Not Applicable.

     

    5

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2022

     

      Rosecliff Acquisition Sponsor I LLC
           
      By: /s/ Michael Murphy
      Name: Michael Murphy
      Title: Chief Executive Officer

     

      Michael Murphy
         
      By: /s/ Michael Murphy

     

    6

     

     

    Exhibit Index

     

    Exhibit 1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.

     

     

    7

     

    Get the next $RCLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RCLF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RCLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dimaio John Michael bought $14,651 worth of shares (4,053 units at $3.61) (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    11/22/23 1:11:01 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Spectral MD Holdings, Ltd. ("Spectral MD" or the "Company") ISO 13485 Certification Received for AI-Driven DeepView® Wound Imaging System

    LONDON and DALLAS, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces that it has received ISO 13485 certification for the manufacture and distribution of its AI-driven DeepView® Wound Imaging System which is designed to provide immediate, accurate, and binary wound treatment assessments for Burn and Diabetic Foot Ulcer (DFU) indications. ISO 13485 is an internationally recognized standard that ensures the quality of medical device design, development, and production. To receive certification, organizations must demonstrate

    8/14/23 7:00:31 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Completion of ISO 13485 Certification Audit

    ISO 13485 Certification Recommended and Anticipated in Q3 2023 Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces it has completed the quality management ISO 13485 certification audit for the manufacture and distribution of its DeepView® Wound Imaging System. ISO 13485 certification has now been recommended and is anticipated in Q3 2023. The completion of the audit validates Spectral MD's commitment to meeting the highest standards of quality, reliability, and safety in the medical device industry. ISO 13485 is an internationally recognized quality standar

    6/20/23 7:00:00 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Announces Publication of Peer Reviewed Proof-of-Concept Study Evaluating DeepView® Technology in Journal of Burn Care & Research

    Results Suggest That Combination of Artificial Intelligence and Multispectral Imaging Can Play an Important Role in Predicting Burn Depth Rapidly and Accurately Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on the development of faster and more accurate medical diagnostics for treatment decisions in wound care, announces today that results from its 2018 Proof of Concept Study were published in the peer-reviewed journal, Journal of Burn Care & Research. The study, titled ‘Clinical Investigation of a Rapid Non-invasive Multispectral Imaging Device Utilizing an Artificial Intelligence Algorithm for Improved Burn Assessment', indicates that Spectral MD

    6/13/23 7:00:00 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    SEC Filings

    View All

    Rosecliff Acquisition Corp I filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    2/13/24 8:21:46 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Rosecliff Acquisition Corp I filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    2/12/24 8:18:27 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Rosecliff Acquisition Corp I

    S-8 - Spectral AI, Inc. (0001833498) (Filer)

    2/9/24 8:33:44 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dimaio John Michael bought $14,651 worth of shares (4,053 units at $3.61) (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    11/22/23 1:11:01 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    Cotton Richard John was granted 14,650 shares, increasing direct ownership by 45% to 47,529 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    11/20/23 1:53:35 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    New insider Spangenberg Erich claimed ownership of 4,736,131 shares (SEC Form 3)

    3 - Spectral AI, Inc. (0001833498) (Issuer)

    9/26/23 8:47:09 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Leadership Updates

    Live Leadership Updates

    View All

    Gett Appoints Chief Information Security Officer

    Runli Guo has joined as Chief Information Security Officer (CISO) and is based in London. Cyber security remains top priority for Gett as its ground transportation platform attracts ever-larger global accounts from Fortune 500 companies. Gett looks to disrupt the $100 billion a year ground transportation management marketplace. Gett – the ground transportation management (GTM) platform for business travel – has confirmed the appointment of Runli Guo as Chief Information Security Officer (CISO). Runli is based in London and reports to Chief Information Officer (CIO) Dina Dembo-Orgil within the Technology and Innovation Function at Gett. Currently around one quarter of Fortune 500 co

    2/9/22 8:00:00 AM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    $RCLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Rosecliff Acquisition Corp I

    SC 13G - Spectral AI, Inc. (0001833498) (Subject)

    2/8/24 4:07:26 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Rosecliff Acquisition Corp I

    SC 13G - Spectral AI, Inc. (0001833498) (Subject)

    11/3/23 4:30:18 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by Rosecliff Acquisition Corp I

    SC 13D - Spectral AI, Inc. (0001833498) (Subject)

    9/26/23 8:48:12 PM ET
    $RCLF
    Medical/Dental Instruments
    Health Care